Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First Benelux Joint Pricing and Reimbursement Pilot Fails Over Vertex’ Orkambi

Executive Summary

The first pilot for the Benelux joint pricing and reimbursement process has failed. Negotiations between Vertex and the ministries of health in Belgium and the Netherlands have ended with no agreement on price for cystic fibrosis drug Orkambi.

Advertisement

Related Content

France In Talks With BeNeLuxA Access To Meds Coalition; Group Plans Expansion Beyond EU
New BeNeLuxA Access To Meds Initiative Pilots Are Under Way
Where Europe’s ‘BeNeLuxA’ Joint Pricing Pilot May Have Gone Wrong
BeNeLuxA Medicine Access Collaboration Plans Joint Horizon Scanning
Vertex Strikes Novel Reimbursement Deal For Cystic Fibrosis Drugs in Ireland
European Pricing Coalition Gathers Momentum

Topics

Advertisement
UsernamePublicRestriction

Register

PS120883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel